Skip to main content
Equibles

STATE STREET CORP

Position in SMMT — Summit Therapeutics Inc.

CIK 93751 BOSTON, MA
Back to SMMT Full portfolio

Position in SMMT

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$138,951,117
+$5,697,204 QoQ
Shares Held
9,536,796
+35.7% QoQ
Ownership
1.20%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#3
of 242 holders
Holding Since
Jun 2021
19 quarters on record
Voting authority Sole 8% Shared 0% None 92%

Common Shares in SMMT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

STATE STREET CORP holds $36,881,619,425 across 411 Biotechnology names. SMMT ranks #65 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 11,871,459 $5,896,909,829
2 REGN
Regeneron Pharmaceuticals, Inc.
 4,834,688 $3,014,621,355
3 INCY
Incyte Corp
 9,722,336 $1,102,124,008
4 MRNA
Moderna, Inc.
 15,726,193 $1,101,305,295
5 ALNY
Alnylam Pharmaceuticals, Inc.
 3,555,689 $1,070,369,059
6 RVMD
Revolution Medicines, Inc.
 4,897,051 $917,119,711
7 RPRX
Royalty Pharma plc
 12,338,229 $691,804,500
8 INSM
INSMED Inc
 6,052,174 $645,282,791

All Filings in SMMT

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $138,951,117 9,536,796
2026-03-31 $133,253,913 7,028,160
2025-12-31 $116,069,953 6,636,361
2025-09-30 $131,437,597 6,361,936
2025-06-30 $85,496,592 4,017,697
2025-03-31 $93,583,274 4,851,388
2024-12-31 $99,983,928 5,602,910
2024-09-30 $75,960,456 3,468,514
2024-06-30 $32,160,468 4,123,137
2024-03-31 $33,592,912 8,114,230
2023-12-31 $6,410,598 2,456,168
2023-09-30 $4,238,484 2,266,569
2023-06-30 $5,657,477 2,253,975
2023-03-31 $214,025 122,300
2022-12-31 $373,575 87,900
2022-03-31 $767,832 313,401
2021-12-31 $906,836 337,114
2021-09-30 $1,684,351 336,198
2021-06-30 $1,914,982 256,700